These results suggest that hepatic LCN2 mediates PCB-induced hepatic inflammation and hepatic lipid and iron accumulation, suggesting that LCN2 is a key pathogenic regulator in PCB-induced NAFLD/NASH models. The gene discussed is LCN2; the disease is metabolic dysfunction-associated steatotic liver disease.